Evidence map›Paper›PMID 20931243›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2011

Combination of intracortically administered VEGF and environmental enrichment enhances brain protection in developing rats.

Naiara Ortuzar, Enrike G Argandoña, Harkaitz Bengoetxea, José V Lafuente

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Naiara OrtuzarDepartment of Neuroscience, Laboratory of Clinical and Experimental Neuroscience (LaNCE), Faculty of Medicine and Odontology, University of the Basque Country UPV/EHU, Barrio Sarriena s/n, E48940 Leioa, Spain. naiara.ortuzar@ehu.es
Enrike G Argandoña
Harkaitz Bengoetxea
José V Lafuente
University of the Basque Country · ESAchucarro Basque Center for Neuroscience · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postnatal development of the visual cortex is modulated by experience, especially during the critical period. In rats, a stable neuronal population is only acquired after this relatively prolonged period. Vascular endothelial growth factor (VEGF) is the most important angiogenic factor and also has strong neuroprotective, neurotrophic and neurogenic properties. Similar effects have been described for rearing in enriched environments. Our aim is to investigate the vascular and neuronal effects of combining VEGF infusion and environmental enrichment on the visual cortex during the initial days of the critical period. Results showed that a small percentage of Cleaved Caspase-3 positive cells colocalized with neuronal markers. The lesion produced by the cannula implantation resulted in decreased vascular, neuronal and Caspase-3 positive cell densities. Rearing under enriched environment was unable to reverse these effects in any group, whereas VEGF infusion alone partially corrected those effects. A higher effectiveness was reached by combining both the procedures, the most effective combination being when enriched-environment rearing was introduced only after minipump implantation. In addition to the angiogenic effect of VEGF, applied strategies also had synergic neuroprotective effects, and the combination of the two strategies had more remarkable effects than those achieved by each strategy applied individually.

Indexed as

EnvironmentNeuroprotective AgentsAnimalsBrainButyrylcholinesteraseCapillariesCaspase 3Cell CountDrug ImplantsFluorescent Antibody Technique, IndirectImmunohistochemistryNerve Tissue ProteinsRatsRats, Long-EvansTissue FixationVascular Endothelial Growth Factor AButyrylcholinesteraseCaspase 3Drug ImplantsNerve Tissue ProteinsNeuroprotective AgentsVascular Endothelial Growth Factor A

Identifiers

PMID20931243
OpenAlexW1982822478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.